Chinese Journal of Antituberculosis ›› 2019, Vol. 41 ›› Issue (5): 488-493.doi: 10.3969/j.issn.1000-6621.2019.05.005
• Original Articles • Previous Articles Next Articles
Zhi-guo SHI1,Yan-hua SONG2(),Ling-hai LI1,Wen-ting ZHAI1,Tao LIU1,Bin CHEN1
Received:
2018-12-21
Online:
2019-05-10
Published:
2019-05-10
Zhi-guo SHI,Yan-hua SONG,Ling-hai LI,Wen-ting ZHAI,Tao LIU,Bin CHEN. The value of protective lung ventilation during anesthesia for tuberculous destructuve pneumonectomy[J]. Chinese Journal of Antituberculosis, 2019, 41(5): 488-493. doi: 10.3969/j.issn.1000-6621.2019.05.005
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2019.05.005
临床特征 | 观察组(24例) | 对照组(24例) | 检验值 | P值 |
---|---|---|---|---|
性别[例(构成比,%)] | 0.483a | 0.800 | ||
男 | 13(54.2) | 16(66.7) | ||
女 | 11(45.8) | 8(33.3) | ||
年龄(岁, | 40.8±14.5 | 38.8±13.2 | 0.681b | 0.503 |
体质量指数( | 21.2±3.0 | 20.7±2.5 | 0.676b | 0.496 |
AS分级[例(构成比,%)] | 0.483a | 0.800 | ||
Ⅱ | 16(66.7) | 13(54.2) | ||
Ⅲ | 8(33.3) | 11(45.8) | ||
FEV1/FVC(%,$\bar{x}$±) | 72.0±8.8 | 71.1±9.7 | 0.802b | 0.431 |
MVV(%,$\bar{x}$±) | 51.5±5.94 | 52.1±6.5 | -0.455b | 0.653 |
麻醉时间(min,$\bar{x}$±s) | 233.1±73.1 | 248.2±67.1 | -1.606b | 0.123 |
OLV时间(min,$\bar{x}$±s) | 191.0±71.4 | 207.0±65.4 | 1.579b | 0.114 |
尿量(ml,$\bar{x}$±s) | 281.3±180.7 | 303.4±153.2 | -1.507b | 0.132 |
术中输血(ml,$\bar{x}$±s) | 818.3±238.1 | 872.6±324.5 | -0.394b | 0.694 |
术中出血(ml, $\bar{x}$±s) | 1181.8±650.3 | 1147.3±567.9 | -1.071b | 0.284 |
输液量(ml, | 3444.1±742.7 | 3471.5±731.4 | -1.320b | 0.113 |
指标 | 观察组 (24例) | 对照组 (24例) | 观察组组内同T1比较 | 对照组组内同T1比较 | 两组间比较 | |||
---|---|---|---|---|---|---|---|---|
F值 | P值 | F值 | P值 | t值 | P值 | |||
Ppeak(cm H2O, | ||||||||
T1 | 20.6±2.4 | 19.8±2.5 | 1.027 | 0.315 | ||||
T2 | 21.0±2.2 | 22.4±2.2 | 1.611 | 0.217 | 4.821 | 0.039 | -2.446 | 0.021 |
T3 | 20.4±2.5 | 20.4±2.3 | 1.000 | 0.328 | 3.189 | 0.087 | 0.077 | 0.939 |
Pplat (cm H2O, | ||||||||
T1 | 19.3±2.8 | 18.5±2.6 | 1.349 | 0.198 | ||||
T2 | 19.7±2.2 | 21.0±2.7 | 0.461 | 0.564 | 7.031 | 0.014 | -3.610 | 0.001 |
T3 | 19.3±2.4 | 18.9±2.8 | 0.249 | 0.623 | 0.263 | 0.613 | 0.723 | 0.477 |
SVV(%, | ||||||||
T1 | 10.9±1.9 | 11.3±1.6 | -0.991 | 0.332 | ||||
T2 | 6.0±2.1 | 6.9±1.5 | 87.932 | 0.000 | 131.612 | 0.000 | -1.722 | 0.098 |
T3 | 9.0±1.5 | 8.7±1.4 | 11.220 | 0.003 | 22.881 | 0.000 | 0.890 | 0.351 |
CI[L/(min·m2), | ||||||||
T1 | 4.0±0.4 | 4.2±0.5 | -1.483 | 0.152 | ||||
T2 | 2.8±0.7a | 2.9±0.4 | 38.738 | 0.000 | 74.741 | 0.000 | -0.943 | 0.356 |
T3 | 3.0±0.6 | 3.1±0.4 | 34.585 | 0.000 | 60.528 | 0.000 | -0.672 | 0.508 |
CVP(mm Hg, | ||||||||
T1 | 9.6±1.6 | 10.3±1.4 | -1.794 | 0.086 | ||||
T2 | 9.3±1.2 | 8.9±1.7 | 0.456 | 0.506 | 11.514 | 0.002 | 0.954 | 0.350 |
T3 | 8.7±1.1 | 8.5±1.5 | 4.879 | 0.037 | 20.509 | 0.000 | 0.607 | 0.550 |
MAP(mm Hg, | ||||||||
T1 | 81.7±7.8 | 79.8±6.3 | 1.287 | 0.211 | ||||
T2 | 70.9±8.8 | 66.6±9.5 | 23.858 | 0.000 | 50.263 | 0.000 | -1.576 | 0.129 |
T3 | 74.2±10.3 | 70.7±7.3 | 8.240 | 0.009 | 21.033 | 0.000 | -1.395 | 0.176 |
指标 | 观察组 (24例) | 对照组 (24例) | 观察组组内同T1比较 | 对照组组内同T1比较 | 组间比较 | |||
---|---|---|---|---|---|---|---|---|
F值 | P值 | F值 | P值 | t值 | P值 | |||
pH( | ||||||||
T1 | 7.4±0.0 | 7.4±0.0 | 0.960 | 0.347 | ||||
T2 | 7.4±0.0 | 7.4±0.0 | 4.634 | 0.053 | 3.260 | 0.084 | 1.565 | 0.131 |
T3 | 7.3±0.1 | 7.4±0.0 | 8.142 | 0.009 | 0.303 | 0.587 | -3.000 | 0.006 |
T4 | 7.4±0.0 | 7.4±0.0 | 7.416 | 0.012 | 3.464 | 0.076 | 0.383 | 0.705 |
PaCO2(mm Hg, | ||||||||
T1 | 39.3±5.0 | 37.8±4.4 | 0.961 | 0.350 | ||||
T2 | 44.0±2.2 | 35.7±4.0 | 36.823 | 0.000 | 89.223 | 0.000 | 7.091 | 0.000 |
T3 | 37.8±4.3 | 36.9±3.8 | 1.468 | 0.238 | 1.292 | 0.267 | 0.832 | 0.414 |
T4 | 37.3±4.5 | 35.2±3.7 | 3.105 | 0.091 | 5.241 | 0.032 | 1.563 | 0.116 |
Qs/Qt(%, | ||||||||
T1 | 10.7±2.9 | 11.0±4.0 | -0.372 | 0.713 | ||||
T2 | 21.4±5.4 | 25.4±6.8 | 63.110 | 0.000 | 89.202 | 0.000 | -0.256 | 0.020 |
T3 | 17.3±5.8 | 17.2±4.1 | 43.124 | 0.000 | 16.145 | 0.001 | -0.652 | 0.521 |
T4 | 7.5±2.6 | 8.8±3.2 | 15.755 | 0.001 | 6.402 | 0.019 | -1.656 | 0.111 |
PaO2/FiO2(mm Hg, | ||||||||
T1 | 426.1±33.8 | 415.6±42.7 | 0.791 | 0.440 | ||||
T2 | 196.8±51.3 | 215.4±97.7 | 344.437 | 0.000 | 81.539 | 0.000 | -0.677 | 0.507 |
T3 | 450.4±24.4 | 437.2±36.3 | 10.544 | 0.000 | 2.825 | 0.106 | 1.422 | 0.173 |
T4 | 181.2±29.0 | 159.1±25.2 | 695.727 | 0.000 | 1308.484 | 0.000 | 2.938 | 0.009 |
[1] | Mandell LA,Wunderink RG,Anzueto A,et al.Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.Clin Infect Dis, 2007,44(2):27-72. |
[2] |
蒋良双,吴邦贵,龚胜,等. 487例结核性毁损肺外科治疗的效果分析.中国防痨杂志,2018, 12(40):1296-1301.
doi: 10.3969/j.issn.1000-6621.2018.12.011 URL |
[3] |
Yum HK,Park IN.Effect of inhaled tiotropium on spirometric parameters in patients with ttuberculous destroyed lung. Tuberc Respir Dis, 2014, 77(4): 167-171.
doi: 10.4046/trd.2014.77.4.167 URL pmid: 4217032 |
[4] |
洪征, 白连启, 阎东杰,等. 肺结核全肺切除近期并发症的治疗. 中华结核和呼吸杂志, 2011, 34(8):582-585.
doi: 10.3760/cma.j.issn.1001-0939.2011.08.011 URL |
[5] |
Kothari A, Baskaran D.Pressure-controlled volume guaranteed mode improves respiratory dynamics during laparoscopic cholecystectomy a comparison with conventional modes. Anesth Esiaessays Res, 2018, 12(1):206-212.
doi: 10.4103/aer.AER_96_17 URL pmid: 29628583 |
[6] |
卞清明, 许仄平, 王丽君, 等. 右美托咪定联合肺保护性通气对胸科手术病人的肺保护作用. 中华麻醉学杂志, 2017, 37(9):1061-1065.
doi: 10.3760/cma.j.issn.0254-1416.2017.09.009 URL |
[7] |
Lin F, Pan L,Huang B, et al.Pressure-controlled versus volume-controlled ventilation during one-lung ventilation in elderly patients with poor pulmonary function. Ann Thorac Med, 2014, 9(4): 203-208.
doi: 10.4103/1817-1737.140125 URL pmid: 4166066 |
[8] | 方建超. PCV与VCV对人工气胸食管癌根治术患者肺功能影响的研究. 郑州:郑州大学,2018. |
[9] |
闫丽娟, 李文志. 胸科手术的单肺通气策略. 国际麻醉学与复苏杂志, 2016, 37(1):49-53.
doi: 10.3760/cma.j.issn.1673-4378.2016.01.012 URL |
[10] |
Blank RS, Colquhoun DA,Durieux ME, et al.Management of one-lung ventilation: impact of tidal volume on complications after thoracic surgery. Anesthesiology, 2016, 124(6): 1286-1295.
doi: 10.1097/ALN.0000000000001100 URL pmid: 27011307 |
[11] |
陈梦媛, 高巨, 郭唯真, 等. 保护性肺通气联合PCV-VG对单肺通气老年患者的肺保护效应.中华麻醉学杂志, 2017, 37(8):902-906.
doi: 10.3760/cma.j.issn.0254-1416.2017.08.002 URL |
[12] |
方向志, 张扬, 高巨. 肺保护性通气对食管癌根治术病人的肺保护效应.中华麻醉学杂志, 2015, 35(3):283-286.
doi: 10.3760/cma.j.issn.0254-1416.2015.03.004 URL |
[13] |
Della Rocca G, Coccia C.Acute lung injury in thoracic surgery. Cur Opin Anesthesiol, 2013, 26(1): 40-46.
doi: 10.1097/ACO.0b013e32835c4ea2 URL pmid: 23235524 |
[14] |
Jeon K, Yoon JW, Suh GY, et al.Risk factors for post-pneumonectomy acute lung injury/acute respiratory distress syndrome in primary lung cancer patients. Anaesth Intensive Care, 2009, 37(1):14-19.
doi: 10.1111/j.1365-2044.2008.05828.x URL pmid: 19157340 |
[15] |
Yeh PH, Hsu PK.An alternative method to achieve one-lung ventilation by surgical pneumothorax in difficult lung isolation patient: a case report. J Anesth, 2015, 30(2):328-330.
doi: 10.1007/s00540-015-2125-6 URL pmid: 26721826 |
[16] |
陈旭, 谢言虎, 柴小青. 肥胖患者单肺通气期间的通气策略.国际麻醉学与复苏杂志, 2016, 37(9):818-821.
doi: 10.3760/cma.j.issn.1673-4378.2016.09.012 URL |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||